Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02221895 · ClinicalTrials.gov registry record · NA

The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months

A NA study, sponsored by Madigan Army Medical Center.

Completed
Registry status
NA
Development phase
344
Enrollment target

NCT02221895: Completed NA study, sponsored by Madigan Army Medical Center.

NCT02221895 is a NA study that has completed, run by Madigan Army Medical Center. The registered enrollment target is 344 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02221895, a NA study, has completed, sponsored by Madigan Army Medical Center.

COMPLETED
Registry status
NA
Development phase
344 participants
Enrollment target

Study Summary

The study's purpose is to determine if early (2-3 week) versus traditional (6-8 week) postpartum follow up is associated with a higher rate of breastfeeding at 6 months. The study's hypothesis is that follow up at 2-3 weeks postpartum is associated with a higher rate of breastfeeding 6 months postpartum.

Primary Outcome

Breastfeeding is defined, for purposes of this study, as any breast milk produced by the mother and fed to the infant (by placing the infant to the breast or by pumping or manually expressing and feeding to the infant by other means). Nominal/categorical assessment (breastfeeding to any degree: yes or no) of breastfeeding will be used to determine the primary outcome.

Interventions

  • OTHER Postpartum follow up appointment 2-3 weeks after delivery
  • OTHER Postpartum follow up 6-8wk after delivery

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2014-03
Est. Completion 2017-05
Phase NA
Madigan Army Medical Center

22 total trials

What the finished NCT02221895 record still lists

NCT02221895 is an interventional study that assigns participants to a tested intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 2 interventions - of which Postpartum follow up appointment 2-3 weeks after delivery is the first listed.

NCT02221895 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02221895 about?

NCT02221895 is a clinical study titled "The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months". The study's purpose is to determine if early (2-3 week) versus traditional (6-8 week) postpartum follow up is associated with a higher rate of breastfeeding at 6 months. The study's hypothesis is that follow up at 2-3 weeks postpartum is associated with a higher rate of breastfeeding 6 months postpa...

What is the current status of trial NCT02221895?

This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2014-03. Estimated completion is 2017-05.

What interventions are being tested in trial NCT02221895?

The interventions under investigation include: Postpartum follow up appointment 2-3 weeks after delivery (OTHER), Postpartum follow up 6-8wk after delivery (OTHER).

Who is sponsoring clinical trial NCT02221895?

This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02221895's enrollment target sits among peer trials

344 302nd of 2000 higher than 1,699 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06733363 · 344 participants · Phase 2

    A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

  • NCT07179380 · 344 participants · Phase 3

    Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • NCT07304024 · 344 participants · Phase 1

    A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

  • NCT03972657 · 345 participants · Phase 1

    A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02221895, the US trial registry maintained by the National Library of Medicine. NCT02221895 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.